We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

21 hedge funds and large institutions have $2.87M invested in Coeptis Therapeutics Warrants in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

58% more capital invested

Capital invested by funds: $1.81M → $2.87M (+$1.06M)

24% more funds holding

Funds holding: 17 → 21 (+4)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$454K
2
KC
Kepos Capital
New York
+$127K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$46.3K
4
BFM
Boothbay Fund Management
New York
+$7.63K
5
PCM
Prelude Capital Management
New York
+$7.63K

Top Sellers

Rank Fund Capital Flow
1
ES
Equitec Specialists
Illinois
-$15K
2
PC
Periscope Capital
Ontario, Canada
-$13.9K
3
VF
Virtu Financial
New York
-$5K
4
Citadel Advisors
Citadel Advisors
Florida
-$102

COEPW Hedge Fund Activity: Q2 2021 in Review

21 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2021, worth a combined $2.87M — up 58% from $1.81M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new COEPW positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $454K. The largest seller was Equitec Specialists, exiting entirely with an estimated $15K sold.

  • 21 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2021, up from 17 in Q1 2021.
  • Funds reported $2.87M of Coeptis Therapeutics Warrants stock for Q2 2021, up 58% quarter-over-quarter.
  • 6 funds opened new Coeptis Therapeutics Warrants positions in Q2 2021 and 2 closed out, a net change of +4 holders.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2021 was Glazer Capital LLC, an estimated $454K added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2021 was Equitec Specialists, an estimated $15K sold.

Based on aggregated 13F filings for Q2 2021.